AAHPM opposes opioid labeling petition at FDA hearing

02/8/2013 | MedPage Today (free registration)

The American Association of Hospice and Palliative Medicine was among the groups represented at an FDA hearing on a petition on the labeling of opioid drugs. AAHPM and other groups said the proposal could block access to opioid drugs for patients with legitimate pain and that there are challenges in implementing rules that seek to distinguish cancer pain and noncancer pain due to the long-term complications of the disease.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY